Key highlights
- BASF commissioned a BioHub fermentation plant at Ludwigshafen with a high double‑digit million‑euro investment.
- Commercial production of biological active ingredients started this year.
- Plant produces Bacillus amyloliquefaciens (basis for Serifel) and Penicillium coprobium (main building block of Inscalis).
- In‑house fermentation is intended to increase production flexibility and supply‑chain resilience.
Investment and purpose
BASF Agricultural Solutions commissioned the BioHub fermentation plant at Ludwigshafen with a high double‑digit million‑euro investment to expand its biological and biotechnology‑based crop protection portfolio.
Production and process
The facility uses microorganisms to convert renewable feedstocks such as glucose into biological active ingredients; commercial production of key actives started this year.
Products
Produced strains include Bacillus amyloliquefaciens (basis for the biological fungicide Serifel) and Penicillium coprobium (the main building block of the insecticide Inscalis).
Operational impact
Bringing fermentation in‑house is intended to increase manufacturing flexibility and enhance supply‑chain resilience for biological crop protection products.
